“Action, Not More Strategies” – Flemingsberg Science in Discussion on Stockholm’s Future Competitiveness

Three days with the spotlight on Sweden’s innovation scene at Science Week x Sweden Innovation Parliament. Here, leading voices came together to explore solutions that build resilient societies, support sustainable industrial production, and secure the skills supply of the future. Flemingsberg Science Foundation was on site to talk about Stockholm’s competitiveness, how to attract new talent to Sweden, and what we as innovation nodes can do to strengthen Sweden’s innovation ecosystem as a whole.

During the panel discussion “The Stockholm Region – Competitiveness in a New Geopolitical Context,”Flemingsberg Science CEO Johnny Högberg participated alongside representatives from Region Stockholm, Kista Science City, Stockholm Science City, Södertälje Science Park, and the Stockholm Region EU Office.

The discussion revolved around how to strengthen Stockholm’s and the Mälardalen region’s role in the global innovation landscape, and several key takeaways emerged.

“During the conversation, we talked about the need for action – not more strategies – to reach our full potential as one of the world’s strongest life science regions. It’s about courage, collaboration, and communication as crucial factors in attracting talent and creating environments where people want to live and thrive. We need to get better at telling our shared story. Stockholm’s strength lies in the diversity of its environments and people, and in our ability to collaborate across boundaries,” said Johnny Högberg

Building a heart: Realheart aims to create new opportunities for patients with heart failure

A mechanical heart, as close to a human heart as it gets. Realheart is the company developing a total artificial heart for patients with advanced heart failure, a condition where treatment options are often limited. When we sit down with CEO Ina Laura Perkins, she tells the story of an innovation that has taken its time, about the strong drive to reach all the way to patients, and about steps that are bringing the company closer to clinical reality.

Go to Top